This work demonstrates that high resolution transmission electron microscopy (HRTEM) is an essential tool to understand drug delivery performance of mesoporous silica materials, mainly those submitted to functionalization processes involving harsh conditions that may affect the mesostructure. Herein a SBA-15-type mesoporous material bearing ≡Si(CH 2 ) 2 P(O)(OCH 2 CH 3 ) 2 groups was synthetized following the cocondensation route. Then, the resulting material was treated with 37% wt. HCl to convert ethylphosphonate groups to ethylphosphonic acid groups. The proper dealkylation of ethoxy groups following acid treatment was confirmed by FTIR and CP-MAS 1 H 13 C solid state NMR, which indicated the presence of ≡Si(CH 2 ) 2 P(O)(OH) 2 functionalities in the treated sample. Characterization of mesoporous materials by XRD diffraction and N 2 adsorption points to well-ordered SBA-15 structures in both untreated and acid-treated samples. Nonetheless, a deep study by HRTEM reveals that the acid-treatment provokes noticeable loss of mesostructural order, only remaining small crystalline domains. This structural damage does not influence cargo loading but it severely affects the release of molecules confined into the mesopores, as concluded from in vitro delivery tests using cephalexin as model drug. Thus, whereas untreated sample showed a sustained diffusion-controlled drug release during more than 2 weeks, 100% of the loaded drug was released only after 10 hours from treated sample. This abrupt burst effect cannot be explained on the basis of the existing matrix-drug interactions, whose nature and extension is quite similar under the release conditions for both samples. Thus, it can be only understood on the basis of the mesostructural damage revealed by HRTEM studies.
iii) high surface area, that provides high potential for drug adsorption; iv) great pore volume to house high amount of therapeutic molecules; v) a silanol-containing surface, which can be functionalized to achieve higher control over drug loading and release.
Understanding drug delivery profiles from mesoporous matrices is essential to exploit their potential as controlled release systems. Drug release process obey four sequential steps: [15] penetration of the release medium into the pore network, which is governed by osmotic pressure derived from concentration gradients; drug dissolution in the release medium; drug diffusion through the porous cavities due to concentration gradients; and drug diffusion and convection within the delivery medium. The structural and textural properties of mesoporous materials together with the chemical nature of their surface are the driving factors that govern the release of molecules and determine drug delivery profiles. [2, 5] Thus, pore diameter is a limiting factor for the diffusion of the molecules to the delivery medium, thus regulating the release rate.[1,16] Pore connectivity and structure also influence drug release kinetics. [17, 18, 20] For instance 3D-bicontinuous cubic mesostructures allow easy fluid accessibility and fast molecular transport than 2D-hexagonal array of pores. [17] However, organic modification or functionalization of mesoporous matrices is cornerstone in the performance of these materials as drug delivery systems. [2, 5, 19, 20] Commonly, functionalization strategies of mesoporous silicas rely on the covalently grafting of organic silanes ((RO) 3 SiR'). [21] M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT

4
This process permits the modification of the silica surface by grafting organic groups selective to the chemical nature of the drug to be hosted. In most cases, organic modification allows increasing host-guest interaction between the mesoporous matrix and the drug molecule. Matrix-drug interactions are usually established through electrostatic or Coulombic interaction, hydrogen bonding, and apolar interaction, [5, 22, 23] offering many possibilities to control drug adsorption and release.
Some functionalization processes require post-synthesis treatments under rather harsh conditions, highlighting those involving strong acids, which could affect the mesostructural order. [24] For instance, the treatment of SBA-15 functionalized with -CN groups followed by treatment with 48 % wt. H 2 SO 4 to oxidize cyanide groups to carboxylic acid groups (-COOH); [25, 26] or the treatment of SBA-15 functionalized with -P(O)(OCH 2 CH 3 ) 2 groups followed by the treatment with 37% wt. HCl to dealkylate phosphonate groups to phosphonic acid groups (-P(O)(OH) 2 ). [27] Whatever the functionalization method used to organically modify the surface of mesoporous matrices, but highlighting those involving aggressive conditions, it is indispensable to deeply study the properties of the resulting materials by using suitable characterization techniques. Actually, any alteration in the mesostructural order could strongly influence drug release process leading to unforeseen delivery profiles, albeit, to the best of our knowledge, this has not been reported yet.
Herein we demonstrate that high resolution transmission electron microscopy (HRTEM) is an essential tool to understand drug release kinetics from mesoporous matrices. For this purpose, SBA-15 incorporating ethylphosphonate functions (-(CH 2 ) 2 P(O)(OH) 2 ) was synthetized by co-condensation route and then was treated with concentrated HCl under reflux to achieve ethylphosphonic acid moieties (-(CH 2 ) 2 P(O)(OH) 2 ). Although X-ray diffraction (XRD) and N 2 adsorption studies point
to well-ordered 2D-hexagonal structures in both samples, in vitro drug delivery profiles are dramatically different, despite of exhibiting similar host-guest interactions under the release conditions. This behavior can be only explained if a deep characterization of samples by HRTEM is performed. Such study reveals that there is a noticeable loss of mesostructure in acid-treated sample, which would account for the rapid and uncontrolled drug release kinetics.
Materials and methods
Synthesis of Materials
SBA-15 type mesoporous silica material containing nominal 15 mol% (based on silicon) phosphonic acid diethyl ester groups (SBA15 DPT ) was synthetized by the cocondensation route using diethylphosphatoethyltriethoxysilane (DPT, 92%, ABCR) (Scheme 1). Briefly, 8.0 g of Pluronic® P123 block copolymer (PEO 20 PPO 70 PEO 20 ) kindly provided by BASF Co.) was added to a mixture of 276 mL of H 2 O and 20.6 mL of concentrated HCl (37% wt., Aldrich). [28] The solution was moderately stirred at 35 ºC until total surfactant dissolution. Then, 14.1 mL of tetraethyl orthosilicate (TEOS, 98% wt., Aldrich) was added. After ca. 20 min a white powder appeared. Then, 3.6 mL of DPT previously dissolved in 18 mL of isopropanol (C 3 H 7 OH, 99.5% wt, Aldrich) was dropwise added to the suspension. The molar composition of the reaction mixture material was soaked into a beaker containing 100 mL of an isooctane-ethanol (3 : 2) mixture (isooctane, ≥99.5% wt, Aldrich; ethanol, 95%, Panreac) and kept under magnetic stirring at room temperature for 48 h. Afterward, the sample was filtered and then subjected to a second extraction process by soaking the powder into 120 mL of an acetone-water (1 : 1) mixture (acetone, QP, Panreac) for 24 h at room temperature under magnetic stirring. After the extraction processes samples were left to dry in a vacuum oven at 40ºC for 24 h to ensure total solvent removal.
Phosphonate ester groups can be transformed readily to phosphonic acid groups by acid-catalyzed hydrolytic dealkylation in concentrated HCl. Thus, SBA-15 type mesoporous silica material containing nominal 15% mol% (based on silicon) phosphonic acid groups (HCl-SBA15 DPT ) was obtained from SBA15 DPT by using a previously reported procedure consisting on treating the SBA15DPT sample with concentrated HCl (Scheme 1). [27] Briefly, 0.5 g of SBA15 DPT sample was refluxed in 50 mL of concentrated HCl (37%, Aldrich) at 100ºC for 24 h. Then sample was filtered, gently washed with deionized water and dried at 60 ºC for 24 h.
Characterization of Materials
The structural characterization of materials was performed by powdered X-ray diffraction (XRD) in a Philips X'Pert diffractometer (Eindhoven, The Netherlands) equipped with CuK α (40 kV, 20 mA) over the range from 0.6 to 6.0º with a step of 0.02º and a contact time of 5 s. Electron microscopy was carried out in a JEOL 3000FEG
The textural properties of materials were determined by N 2 adsorption porosimetry.
The N 2 adsoption/desorption analyses were carried out at -196 ºC on a Micromeritics ASAP2020 analyzer (Micromeritics Co., Norcross, USA). In all cases, 50-70 mg of material was degasses at 80 ºC for 24 h under a vacuum lower than 0.3 kPa before the analysis. The surface area (S BET ) was determined from adsorption data obtained at P/P 0 between 0.05 and 0.2 by using the Brunauer-Emmett-Teller (BET) method. [30] The total pore volume was estimated from the amount of N 2 adsorbed at a relative pressure of 0.97, assuming that adsorption on the external surface was negligible compared to adsorption in pores. To assess the possible existence of micropores (pore diameter < 2 nm) in samples, the t-plot method was employed, [31] which allowed the estimation of the microporous fraction contributions, V µP and S µP , to the total pore volume and surface area, respectively. The average mesopore size (D P ) was obtained from the maximum of the pore size distribution calculated from the adsorption branch of the isotherm using the BJH method. [32] The wall thickness (t wall ) was calculated by using the expression t wall = a 0 -D P , where a 0 is the unit cell parameter calculated from the d 10 value of XRD using the expression a 0 = d 10 × 2/ /√3. [33] The existence of functional groups and their chemical nature were investigated by Fourier transform infrared spectroscopy (FTIR) in a Thermo Nicolet Nexus spectrometer equipped with a Goldengate attenuated total reflectance (ATR) device (Thermo scientific, USA). Quantitative determination of phosphorus in functionalized samples was determined by using X-ray fluorescence spectroscopy (XRF) in a Philips PANanalytical AXIOS spectrometer (Philips Electronics NV). X-ray were generated using the R h K α line at λ = 0.614 Å. The amount of residual surfactant in samples was calculated from elemental chemical analysis and thermal analyses (TG and DTA). 
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In vitro Drug Loading and Release
Cephalexin ( To carry out in vitro CPX release assays, 35 mg of each drug loaded powder sample was compacted into disks of 6 mm in diameter and 2 mm in height by using uniaxial pressure at 2.75 MPa. Then, the disks were hung in screw caps using platinum wire and The apparent drug release was normalized to the amount of drug loaded within the samples to calculate the relative amount of drug release. The CPX concentration was determined from the average of the readings from three different samples (N = 3), and data were presented as mean ± standard deviation.
Results and Discussion
Materials Characterization
The chemical nature of samples was investigated by using FTIR, CHNS elemental chemical analysis, XRF and solid-state NMR spectroscopy. suggests the participation of phosphoryl groups in the formation of hydrogen bond.
The successful conversion of -PO(OCH 2 CH 3 ) 2 into -PO(OH) 2 groups after treatment of SBA15 DPT sample with HCl is evidenced in the FTIR spectrum of HCl-SBA15 DPT , which exhibit distinct differences from that of SBA15 DPT (Fig.1) . First, the three peaks 29 Si NMR spectra into individual Gaussian peaks. The assignation of the resonance signals from the spectra is displayed Fig. 3 and the relative peak areas are shown in Table 1 . It should be noticed that the surface area (S BET ) of HCl-SBA15 DPT sample (364 m 2 /g) experiences a decrease of 25% with respect to that of SBA15 DPT (466 m 2 /g). The total pore volume (V P ) is preserved, being ca. 5 cm 3 /g for both samples, although there is a decrease in the micropore volume in HCl-SBA15 DPT . The pore diameters (D P ) are 7.4 and 8.7 nm for SBA15 DPT and HCl-SBA15 DPT , which points to and enlargement of the mesopore size and a broadening in the pore size distribution of the material after the acid treatment ( Fig. 5.B) . Nonetheless, as the network lattice (a 0 ) also experiences an expansion after the HCl reflux, the wall thickness (t wall ) remains constant, ca. 5 nm, for both materials.
XRD and N 2 adsorption porosimetry studies indicate that even after being submitted to the relative harsh acidic conditions, HCl-SBA15 DPT sample preserves the well-
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16 ordered 2D hexagonal structure typical of SBA-15, whereas only exhibits slight modifications in its textural properties compared to SBA15 DPT . Accordingly, HCl-SBA15 DPT shows slightly smaller surface area (S BET ), micropore area (S µP ) and micropore volume (V µP ), and greater pore diameter than SBA15 DPT sample.
In vitro drug loading and release
To investigate the performance of both matrices as drug delivery devices, their adsorption and release behavior was in vitro evaluated using cephalexin (CPX) as model drug. Loading assays were carried out by soaking powdered samples in water (pH ∼ 6), and CPX release experiments were carried out at the physiological pH of 7.4. [40] In the aqueous medium the CPX molecule exhibit different ionization states depending on the pH, which is due to the presence of one carboxylic acid group and one amine group into its structure (Fig. 6 ).
With the aim of understanding the interaction of CPX with the different mesoporous samples, the possible ionization equilibria in aqueous media and their corresponding constants depending on the grafted functional groups are displayed below: In vitro drug release assays were performed in PBS under physiological conditions (pH 7.4 and 37 ºC). Fig. 7 shows CPX release patterns from both mesoporous matrices.
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The main driving force that usually governs drug departure from mesoporous matrices is pore diffusion/convection, which can be fitted to first order kinetics. [29, 44] In addition, the carrier-drug host-guest interactions play a key role in drug release kinetics from mesoporous materials. In this sense, drug molecules may directly interact with mesoporous matrices, lowering their solubility and/or retaining their release. In such a case, drug molecules are termed as associated, which need to be disassociated from nanocarriers prior to release. The association and dissociation processes are assumed to be reversible and also follow first order kinetics. Therefore, the theoretical model adopted in this work considers both first-order diffusion/convection and drug association/dissociation processes. [44] Then, the drug release mechanism can be described by the following equation:
where M t is the cumulative drug release at time t; M 0 is the initial amount of drug; k s is the rate constant of diffusion/convection; and k on and k off are the rate constants of association and disassociation, respectively. The free energy difference between the free and bound states, ∆G, determines the amounts of initially free and bound drug, and can be calculated by the equation:
where, k B is the Boltzmann's constant and T is the absolute temperature (assumed to be 310 K). In this study, therefore, three parameters, ∆G (instead of k on ), k s and k off were used to describe the cumulative drug release from mesoporous silica materials.
CPX release from SBA15 DPT is characterized by a high initial burst release (> 30%)
followed by a steady-state release, which corresponds to category III of drug release profiles classification reported by Ye et al. [45] The fit of the experimental CPX release patterns from SBA15 DPT to Eq. 5 allows determining the experimental values for k s , k on and k off . Then ∆G was calculated using Eq. 7. The obtained results, which properly fit to the theoretical model (R 2 = 0.9995), are summarized in Table 3 J. This burst release may occur to equilibrate the concentrations in both the release medium and the matrix, albeit it has been also ascribed to the release of the molecules adsorbed in the outer surface of mesoporous matrices [19, 20] . k s provides information about the rate of diffusion/convection, but not about the magnitude of the initial burst release. The model reveals a k s value of 0.98 h -1 for SBA15 DPT , which accounts for a moderated diffusivity of the drug confined into the mesoporous channels. The carrier-drug host-guest interactions can be related to the k off value, which is 5.7 × 10 -23 h -1 . The k off value gives information about the steady release following initial burst release, but has no effect on the magnitude of initial burst release.
Once the CPX concentration inside mesopores decreases obeying a burst effect, a sustained steady-state release where 93% of CPX is released after 2 weeks of assay occurs.
In principle, CPX release profile from HCl-SBA15 DPT mesoporous material would be expected to be similar to that of SBA15 DPT . This would be supported by the fact that the number of Brönsted acid groups susceptible of undergoing deprotonation is similar, ca.
5×10
-21 groups per gram of material, in both cases (Table 1) that of HCl-SBA15 DPT (S µP = 18 m 2 /g) could also contribute to a slower drug release out of the pores in the former. In this sense, drug molecules would be expected to have stronger interactions with the host in the sequestered volume provided by the micropores, which would lead to more sustained release kinetics. [46] Even though taking into consideration the above-mentioned aspects, drug release profile of HCl-SBA15 DPT drastically differs from than that of SBA15 DPT (Fig. 7) . The curve consists of an abrupt burst release where 100% of the drug is released only after 10 hours of assay. It can be classified as the Case 1 release model reported by Zeng et al., [44] which corresponds to the fast disassociation of drug molecules from the carrier such that k off >>k on . As a result, most of the drug molecules are initially free and the drug release profile is determined by diffusion and convection only. In this case, the solution in Eq. 6 can be reduced to:
The good fit of the experimental data of drug release from HCl-SBA15 DPT to Eq. 8 (R 2 = 0.9991) provides a k s value of 1.10 h -1 , which is only slightly higher than that of SBA DPT (0.98 h -1 ). This could be explained by the greater pore diameter of the former.
Nonetheless, the lack of steady-state release since almost 100% of CPX is released during a burst effect cannot be explained neither considering the chemical nature nor the structural and textural properties of HCl-SBA15 DPT derived from XRD and N 2 adsorption studies.
In the search for new insights about possible mesostructural damages that allow explaining the different drug release performance of mesoporous matrices, an M A N U S C R I P T A C C E P T E D Fig. 8 and Fig. 9 , respectively. EDS analysis was performed during the TEM observation. Si, O and P peaks appear in both samples. The average P percentage is 3.6 and 1.7 for SBA15 DPT and HCl-SBA15 DPT , respectively. Fig. 8 confirms that SBA15 DPT sample exhibits a honeycomb mesoporous arrangement typical of SBA-15, in agreement with XRD patterns. However, TEM images of HCl-SBA15 DPT reveal that there is a noticeable of loss of the mesostructural order ( Fig. 9) , with only small crystalline domains. This mesostructure loss in HCl-SBA15 DPT due to the acid treatment, which was not detected by XRD, would explain the very different drug release profile of this sample. Albeit the extent of mesostructural order does not affect drug loading, since as above mentioned acid-treated sample loads higher amounts of CPX than untreated sample, it plays a pivotal role in drug release kinetics from mesoporous matrices.
Nonetheless there is another factor that should be also taken into account, since it has been reported that mesoporous matrices can undergo degradation when soaked in diverse fluids under physiological conditions. [48, 49, 50] A previous study carried out by our research group [49] aimed at comparing the degradation of several SBA-15 type mesoporous materials, i.e. pure silica SBA-15 and SBA-15 functionalized with alkoxysilanes bearing different organic groups such as aminopropyl, methyl or octyl.
The results indicated that whereas SBA-15 was partially soluble in all tested media, organic modification leaded to the decrease in the degradation rate of mesoporous matrices, which was accompanied by preservation of the mesostructural order even after
applications, including drug delivery, are aimed, which require mesoporous matrices with stable mesostructural order. However, the influence of mesoporous matrix degradation on drug release performance was not evaluated, and it is an interesting topic that will be the object of our future investigations. Finally, CPX release assays for all materials submitted to HCl treatment revealed that all drug release profiles are similar, obeying an initial burst where 100% of the loaded drug is released a few hours of assay for all materials (Figs. S1, S2 and S3).
All these findings demonstrate that the partial loss of mesostructure, which can be only detected by HRTEM, drastically affects drug delivery by promoting the complete drug delivery during a fast burst release effect.
Conclusions
Deep characterization of mesoporous materials by HRTEM is indispensable to understand their performance as drug delivery devices. This tool becomes of foremost relevance to study functionalized mesoporous samples that have to be submitted to assay. This behavior completely differs from that found in the well-ordered untreated sample which, despite of exhibiting comparable matrix-drug interactions under the release conditions, shows sustained diffusion-controlled drug delivery for more than 2 weeks. S BET and S µP are respectively the surface area determined by using the BET method between the relative pressures (P/P 0 ) 0.05-0.25 and micropore surface obtained using the t-plot method. V P and V µP are respectively, the total pore volume and micropore volume obtained using the t-plot method. The total pore volume was estimated from the amount of N 2 adsorbed at a relative pressure of 0.97. D P is the pore diameter calculated by means of the BJH method from the adsorption branch of the isotherm. a 0 is the unit cell parameter calculated by XRD, being a 0 =2/√3.d 10 . t wall is the wall thickness calculated using the equation t wall = a 0 -D P . The number of -(CH 2 ) 2 P(O)(OX) 2 groups per nm 2 , where X = CH 2 CH 3 and X=H for SBA15 DPT and HCl-SBA15 DPT , respectively, was calculated on the basis of XRF. The number of silanol groups (SiOH) was determined by single pulse 29 Si solid state NMR spectroscopy, as described in the experimental section. HCl-SBA15 DPT 
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